Skip to main content
logo
Ovid Therapeutics Inc. (OVID)
NASDAQ: OVID · Real-Time Price · USD
2.630
+0.010 (0.38%)
Aug 6, 2026, 10:48 AM EDT - Market open

Ovid Therapeutics Revenue

Ovid Therapeutics had revenue of $7.12M in the twelve months ending March 31, 2026, up 1,199.64% year-over-year. In the year 2025, Ovid Therapeutics had annual revenue of $7.25M with 1,181.27% growth.

Revenue (ttm)
$7.12M
Revenue Growth
+1,199.64%
P/S Ratio
68.66
Revenue / Employee
$309,652
Employees
23
Market Cap
490.86M

Revenue Chart

Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20257.25M6.69M1,181.27%
Dec 31, 2024566.00K174.00K44.39%
Dec 31, 2023392.00K-1.11M-73.91%
Dec 31, 20221.50M-206.88M-99.28%
Dec 31, 2021208.38M195.77M1,551.57%
Dec 31, 202012.62M--
Dec 31, 2019---
Dec 31, 2018---
Dec 31, 2017---
Dec 31, 2016---
Dec 31, 2015---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Prothena Corporation57.94M
Q32 Bio53.74M
Prelude Therapeutics16.72M
Evommune10.00M
Ocugen4.47M
Inhibikase Therapeutics1.00
Revenue Rankings

OVID News

More News